Kane Biotech Inc V.KNE

Alternate Symbol(s): KNBIF

Healthcare Biotechnology

Kane Biotech Inc. is a Canada-based biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies, intellectual property (68 patents and patents pending, trade secrets and trademarks) and products developed by its own biofilm research expertise and acquired from research institutions. DispersinB, Aledex, coactiv+, coactiv+, DermaKB, DermaKB Biofilm, and revyve are trademarks of the Company. Its patented coactiv+ technology is specifically formulated to destabilize biofilm and create an environment for fast wound healing. In Wound Care & Surgical applications, in addition to revyve Antimicrobial Wound Gel, it is developing follow-on products with three applications: coactiv+ Antimicrobial Surgical Hydrogel, coactiv+ Antimicrobial Wound Gel Spray, and coactiv+ Antimicrobial Wound Rinse. The Company's other biofilm disruption technology is DispersinB.

TSXV:KNE - Post by User

Kane Biotech Inc

Bullboard Posts

Comment by siboon Jul 08, 2011 4:21pm

251 Views

Post# 18812504

RE: Pump le dump

>>You are the biggest pumper, day trader and a lying SOB. You were probably the first one to sell once it hit .30s.<<

If you "speak the truth" end the slander. If you read PC's posts carefully it's clear he was a believer, not a pumper. It's doubtful he sold A SINGLE SHARE.

And, if you're dull enough to buy based on Stockhouse postings many more have a bridge for you.

Bullboard Posts

Visionstate set to leverage success in the U.S. market